Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotrecept for post–allo-HSCT anemia in acute leukemia
ChiCTR2600122050Phase 4Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Apr 2026
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of luspatercept in anaemia and Acute Leukaemia, sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Proportion of patients with improved transfusion response. Started Apr 2026; status: recruiting.
02
Drugs
luspatercept
03
Conditions
anaemiaAcute Leukaemia
Beyond the preview
Go deeper on ChiCTR2600122050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122050.